Jan 24 (Reuters) - Zosano Pharma Corp (ZSAN):
* ZOSANO PHARMA CORP (ZSAN) - ON JAN 18,, RESUBMITTED ITS M207 (ZOLMITRIPTAN TRANSDERMAL MICRONEEDLE SYSTEM) 505(B)(2) NDA TO U.S. FDA Source: (https://bit.ly/3Iyexg8) Further company coverage: